Madison Square Garden Sports (NYSE: MSGS) has filed a Form 10 Registration Statement with the SEC to formally advance a…
Read More
Hyperscale Data, Inc. Files Form 8-K with SEC for NYSE-Listed Class A Common Stock (GPUS) – April 10, 2026 – Minichart
Hyperscale Data, Inc. Files Form 8-K – Key Shareholder Votes and Amfinishments Summary of Key Developments Hyperscale Data, Inc. (NYSE:…
Read More
Hostplus Bitcoin, SEC Token Rules & AI Shifts
The crypto market shifts quick, so it’s simple to miss what really matters during the week. Important updates, price shifts,…
Read More
SEC, CSE urge SOEs to utilize capital market as a source of funding
ECONOMYNEXT – The Securities and Exalter Commission of Sri Lanka (SEC) and the Colombo Stock Exalter (CSE) hosted a forum…
Read More
XRP Treasury Evernorth Files SEC Form S-4 for Nasdaq Listing
The company announced plans to go public in October 2025 through a merger with special purpose acquisition company Armada Acquisition…
Read More
Clinical-Stage Biopharma Progress, Revenue Risks, and SEC Filing Highlights – Minichart
Zeo ScientifiX, Inc. Q1 2026 Financial Report: Key Highlights and Investor Takeaways Summary of the Report Zeo ScientifiX, Inc. (OTC:…
Read More
Nigeria records $96 billion crypto transactions – SEC
Director-general of the Securities and Exalter Commission (SEC), Emomotimi Agama, has disclosed that Nigeria’s digital finance ecosystem recorded about $96bn…
Read More
Amfinished and Restated Articles of Incorporation Filed for BOTY with SEC – XBRL and Exhibit Details Included 5 – Minichart
Lingerie Fighting Championships, Inc. – Detailed Investor Update on Significant Corporate Actions Key Points from the Report Significant Increase in…
Read More
XBP Global Holdings, Inc. Files Form 8-K with SEC – Company Information, Address, and Security Details for March 6, 2026 – Minichart
XBP Global Holdings, Inc. Files Form 8-K: Key Developments and Shareholder Impact XBP Global Holdings, Inc. (NASDAQ: XBP) has submitted…
Read More
Aclaris Therapeutics, Inc. 8-K SEC Filing Summary – Company Information & Details (March 9, 2026) – Minichart
Aclaris Therapeutics, Inc. Raises \$39.8 Million in Common Stock Offering to Institutional Investors WAYNE, PA – March 9, 2026 –…
Read More
